Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 994 entries
View as:

PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01212757 Org: User:
Start: 09/27/10 End: 01/25/17 Due: 01/25/18

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03256344 Org: User:
Start: 03/19/18 End: 12/03/21 Due: 12/03/22

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT03969329 Org: User:
Start: 12/20/19 End: 06/30/25 Due: 06/30/26

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00422019 Org: User:
Start: 01/31/07 End: 03/31/09 Due: 03/31/10

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00858364 Org: User:
Start: 07/17/09 End: 06/07/17 Due: 06/07/18

Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04887064 Org: User:
Start: 04/22/21 End: 03/09/22 Due: 03/09/23

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02102204 Org: User:
Start: 03/25/14 End: 06/26/17 Due: 06/26/18

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00094484 Org: User:
Start: 10/31/04 End: - Due: -

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02263508 Org: User:
Start: 12/08/14 End: 03/11/21 Due: 03/11/22

Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)

Phase: N/A Priority: Normal
NCT ID: NCT06649006 Org: User:
Start: 01/08/25 End: 09/28/25 Due: 09/28/26

A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)

Phase: N/A Priority: Normal
NCT ID: NCT01544114 Org: User:
Start: 04/30/12 End: 02/28/15 Due: 02/28/16

Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01464931 Org: User:
Start: 11/30/11 End: 03/31/13 Due: 03/31/14

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Phase: N/A Priority: Normal
NCT ID: NCT02101164 Org: User:
Start: 11/30/14 End: 11/30/14 Due: 11/30/15

A Study of AMG 557 in Adults With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00774943 Org: User:
Start: 12/31/08 End: 05/31/12 Due: 05/31/13

Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01181531 Org: User:
Start: 10/01/10 End: 08/14/12 Due: 08/14/13

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06117774 Org: User:
Start: 02/20/24 End: 10/31/29 Due: 10/31/30

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05891119 Org: User:
Start: 06/03/23 End: 12/26/24 Due: 12/26/25

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Phase: N/A Priority: Normal
NCT ID: NCT04478994 Org: User:
Start: 11/17/21 End: 12/08/22 Due: 12/08/23

A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin

Phase: N/A Priority: Normal
NCT ID: NCT00148369 Org: User:
Start: 06/30/05 End: 09/30/07 Due: 09/30/08

STAAR-3 Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT00369733 Org: User:
Start: 05/31/02 End: 05/31/04 Due: 05/31/05

Fixed Dose NESP Study in Subjects With CRI

Phase: N/A Priority: Normal
NCT ID: NCT00526929 Org: User:
Start: 05/31/00 End: 02/28/02 Due: 02/28/03

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00472290 Org: User:
Start: 04/01/07 End: 12/26/11 Due: 12/26/12

The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01001208 Org: User:
Start: 11/30/09 End: 02/28/11 Due: 02/28/12

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00515203 Org: User:
Start: 07/31/07 End: 08/31/09 Due: 08/31/10

NESP Pediatric Study

Phase: N/A Priority: Normal
NCT ID: NCT00527137 Org: User:
Start: 08/31/00 End: 11/30/04 Due: 11/30/05